TY - JOUR
T1 - On the use of the healthy lifestyle index to investigate specific disease outcomes
AU - Viallon, Vivian
AU - Freisling, Heinz
AU - Matta, Komodo
AU - Nannsen, Anne Østergaard
AU - Dahm, Christina C.
AU - Tjønneland, Anne
AU - Eriksen, Anne Kirstine
AU - Kaaks, Rudolf
AU - Katzke, Verena A.
AU - Schulze, Matthias B.
AU - Masala, Giovanna
AU - Tagliabue, Giovanna
AU - Simeon, Vittorio
AU - Tumino, Rosario
AU - Milani, Lorenzo
AU - Derksen, Jeroen W.G.
AU - van der Schouw, Yvonne T.
AU - Nøst, Therese Haugdahl
AU - Borch, Kristin Benjaminsen
AU - Sandanger, Torkjel M.
AU - Quirós, J. Ramón
AU - Rodriguez-Barranco, Miguel
AU - Bonet, Catalina
AU - Aizpurua-Atxega, Amaia
AU - Cirera, Lluís
AU - Guevara, Marcela
AU - Sundström, Björn
AU - Winkvist, Anna
AU - Heath, Alicia K.
AU - Gunter, Marc J.
AU - Weiderpass, Elisabete
AU - Johansson, Mattias
AU - Ferrari, Pietro
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/7/15
Y1 - 2024/7/15
N2 - The healthy lifestyle index (HLI), defined as the unweighted sum of individual lifestyle components, was used to investigate the combined role of lifestyle factors on health-related outcomes. We introduced weighted outcome-specific versions of the HLI, where individual lifestyle components were weighted according to their associations with disease outcomes. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we examined the association between the standard and the outcome-specific HLIs and the risk of T2D, CVD, cancer, and all-cause premature mortality. Estimates of the hazard ratios (HRs), the Harrell’s C-index and the population attributable fractions (PAFs) were compared. For T2D, the HR for 1-SD increase of the standard and T2D-specific HLI were 0.66 (95% CI: 0.64, 0.67) and 0.43 (0.42, 0.44), respectively, and the C-index were 0.63 (0.62, 0.64) and 0.72 (0.72, 0.73). Similar, yet less pronounced differences in HR and C-index were observed for standard and outcome-specific estimates for cancer, CVD and all-cause mortality. PAF estimates for mortality before age 80 were 57% (55%, 58%) and 33% (32%, 34%) for standard and mortality-specific HLI, respectively. The use of outcome-specific HLI could improve the assessment of the role of lifestyle factors on disease outcomes, thus enhancing the definition of public health recommendations.
AB - The healthy lifestyle index (HLI), defined as the unweighted sum of individual lifestyle components, was used to investigate the combined role of lifestyle factors on health-related outcomes. We introduced weighted outcome-specific versions of the HLI, where individual lifestyle components were weighted according to their associations with disease outcomes. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we examined the association between the standard and the outcome-specific HLIs and the risk of T2D, CVD, cancer, and all-cause premature mortality. Estimates of the hazard ratios (HRs), the Harrell’s C-index and the population attributable fractions (PAFs) were compared. For T2D, the HR for 1-SD increase of the standard and T2D-specific HLI were 0.66 (95% CI: 0.64, 0.67) and 0.43 (0.42, 0.44), respectively, and the C-index were 0.63 (0.62, 0.64) and 0.72 (0.72, 0.73). Similar, yet less pronounced differences in HR and C-index were observed for standard and outcome-specific estimates for cancer, CVD and all-cause mortality. PAF estimates for mortality before age 80 were 57% (55%, 58%) and 33% (32%, 34%) for standard and mortality-specific HLI, respectively. The use of outcome-specific HLI could improve the assessment of the role of lifestyle factors on disease outcomes, thus enhancing the definition of public health recommendations.
KW - Cancer
KW - Cardiovascular diseases
KW - Composite score
KW - Healthy lifestyle index
KW - Lifestyle factors
KW - Mortality
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85198639440&partnerID=8YFLogxK
U2 - 10.1038/s41598-024-66772-w
DO - 10.1038/s41598-024-66772-w
M3 - Article
AN - SCOPUS:85198639440
SN - 2045-2322
VL - 14
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 16330
ER -